Skip to main content
. 2022 Mar 23;2022:3307873. doi: 10.1155/2022/3307873

Figure 3.

Figure 3

SETDB1 expression in different disease stages and treatment response. (a) SETDB1 expression was increased in the relapsed group (n = 347) in comparison with the baseline group (n = 127) in the TT2 group from GSE31161 (p < 0.05, Wilcoxon test), but there was no difference in the TT3 group. (b) SETDB1 expression was different in MM patients with the response (n = 28) and no response (n = 42) in the DEX treatment group from GSE9782 (p < 0.05, Wilcoxon test), and there was no difference in the PS341 treatment group. The x-axis represents different groups, and the y-axis represents gene expression. SETDB1 gene expression was measured as log2.